Aldurazyme and Abdominal discomfort - a phase IV clinical study of FDA data

Summary:

Abdominal discomfort is found among people who take Aldurazyme, especially for people who are male, 20-29 old, have been taking the drug for 5 - 10 years.

The phase IV clinical study analyzes which people take Aldurazyme and have Abdominal discomfort. It is created by eHealthMe based on reports of 3,621 people who have side effects when taking Aldurazyme from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Aug, 05, 2022

3,621 people reported to have side effects when taking Aldurazyme.
Among them, 17 people (0.47%) have Abdominal discomfort.


What is Aldurazyme?

Aldurazyme has active ingredients of laronidase. eHealthMe is studying from 3,622 Aldurazyme users for its effectiveness, alternative drugs and more.

What is Abdominal discomfort?

Abdominal discomfort is found to be associated with 3,601 drugs and 2,645 conditions by eHealthMe.

Number of Aldurazyme and Abdominal discomfort reports submitted per year:

Could Aldurazyme cause Abdominal discomfort?

Time on Aldurazyme when people have Abdominal discomfort *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 33.33 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 66.67 %
  • 10+ years: 0.0 %

Gender of people who have Abdominal discomfort when taking Aldurazyme *:

  • female: 37.5 %
  • male: 62.5 %

Age of people who have Abdominal discomfort when taking Aldurazyme *:

  • 0-1: 0.0 %
  • 2-9: 15.38 %
  • 10-19: 7.69 %
  • 20-29: 38.46 %
  • 30-39: 23.08 %
  • 40-49: 15.38 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Aldurazyme *:

  1. Humira: 2 people, 11.76%

Common side effects people have besides Abdominal discomfort *:

  1. Pain: 9 people, 52.94%
  2. Corneal Disorder: 7 people, 41.18%
  3. Pulmonary Congestion (congestion in the lungs): 7 people, 41.18%
  4. Malaise (a feeling of general discomfort or uneasiness): 7 people, 41.18%
  5. Peripheral Swelling: 7 people, 41.18%
  6. Pleural Effusion (water on the lungs): 7 people, 41.18%
  7. Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 6 people, 35.29%
  8. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 35.29%
  9. Head Injury: 6 people, 35.29%
  10. Fall: 6 people, 35.29%

* Approximation only. Some reports may have incomplete information.

Do you take Aldurazyme and have Abdominal discomfort?

Check whether Abdominal discomfort is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Aldurazyme:

Abdominal discomfort treatments and more:

COVID vaccines that are related to Abdominal discomfort:

How severe was Abdominal discomfort and when was it recovered:

Expand to all the drugs that have ingredients of laronidase:

Common drugs associated with Abdominal discomfort:

All the drugs that are associated with Abdominal discomfort:

Common conditions associated with Abdominal discomfort:

All the conditions that are associated with Abdominal discomfort:

How the study uses the data?

The study uses data from the FDA. It is based on laronidase (the active ingredients of Aldurazyme) and Aldurazyme (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: